comparemela.com
10
11
12
13
14
15
16
Latest Breaking News On - Ugur sahin - Page 9 : comparemela.com
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update | Company Announcement
Investegate announcements from BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
Germany
China
United-states
American
German
Ugur-sahin
Genmabas-genmab
Annemarie-hanekamp
Sean-marett
Fosun-pharma
Biontech-fixvac
Jens-holstein
What's Going With BioNTech Stock On Monday? - BioNTech (NASDAQ:BNTX)
BioNTech reports Q1 loss, missing revenue expectations. Despite challenges, BioNTech aims for significant growth, fueled by innovative R&D and strong cash reserves.
Ugur-sahin
Jens-holstein
Partner-pfizer-inc
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
German Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply lower net revenues.
Germany
German
Ugur-sahin
Nasdaq
Biopharmaceutical-new-technologies
Biontech
Covid-19
Covid-19-vaccine
Ugur-sahin
Iontech-loss
Iopharmaceutical-new-tech
BioNTech : Compensation Report for the 2023 financial year
Compensation Report of BioNTech SE, Mainz, December 31, 2023 A. Compensation Report .
Germany
German
Ryan-richardson
Sean-marett
Jens-holstein
Ugur-sahin
Sierk-poetting
James-ryan
Terms-of-the-current-service-agreements
Management-board
Option-plans
Option-plan
BioNTech : Report of the Management Board on Agenda Item 10 (pursuant to sections 71 para. 1 no. 8, 186 para. 4 sentence 2 AktG)
English Convenience Translation - the German language is decisive Annual General Meeting of BioNTech SE on 17 May 2024 .
United-states
Germany
American
German
Ugur-sahin
Jens-holstein
James-ryan
Sierk-poetting
Ryan-richardson
Sean-marett
Performance-share-unit-program
Company-management-board
vimarsana © 2020. All Rights Reserved.